These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17895822)

  • 41. The eye and thyroid disease.
    Kuriyan AE; Phipps RP; Feldon SE
    Curr Opin Ophthalmol; 2008 Nov; 19(6):499-506. PubMed ID: 18854695
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Orbital radiotherapy for thyroid eye disease.
    Dolman PJ; Rath S
    Curr Opin Ophthalmol; 2012 Sep; 23(5):427-32. PubMed ID: 22729183
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stereotactic radiotherapy for unilateral orbital lymphoma and orbital pseudo-tumors: a planning study.
    Chino K; Tanyi JA; Stea B
    Med Dosim; 2009; 34(1):57-62. PubMed ID: 19181257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Management of Graves' orbitopathy: evidence-based recommendations].
    Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ
    Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Thyroid orbitopathy, an overview with special attention to the role of radiotherapy].
    Vilar-González S; Lamas-Oliveira C; Fagúndez-Vargas MA; Núñez-Quintanilla AT; Pérez-Rozos A; Merayo-Lloves J; Escobar-Barranco JJ; Rico-Pérez JM
    Endocrinol Nutr; 2015 Apr; 62(4):188-99. PubMed ID: 25637365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endoscopic orbital decompression for optic neuropathy in thyroid ophthalmopathy.
    Tang IP; Prepageran N; Subrayan V; Tajunisah I
    Med J Malaysia; 2008 Oct; 63(4):337-8. PubMed ID: 19385499
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current trends in the management of thyroid eye disease.
    Rao R; MacIntosh PW; Yoon MK; Lefebvre DR
    Curr Opin Ophthalmol; 2015 Nov; 26(6):484-90. PubMed ID: 26397888
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Radiotherapy of Graves' ophthalmopathy--state of the art and review of the literature].
    Eich HT; Micke O; Seegenschmiedt MH
    Rontgenpraxis; 2007; 56(4):137-44. PubMed ID: 17390953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of pharyngeal and laryngeal complications in adult asthmatics using inhaled corticosteroids.
    Bhalla RK; Jones AS; Roland NJ
    J Laryngol Otol; 2008 Oct; 122(10):1078-83. PubMed ID: 18201390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of previous radiation exposure on pathologic features and clinical outcome in patients with thyroid cancer.
    Seaberg RM; Eski S; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):355-9. PubMed ID: 19380356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The expression of interleukin-15 and interleukin-17 in tears and orbital tissues of Graves ophthalmopathy patients.
    Chen Q
    J Cell Biochem; 2019 Apr; 120(4):6299-6303. PubMed ID: 30565709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monoclonal anti-TNFalpha antibody (infliximab) in the treatment of patient with thyroid associated ophthalmopathy.
    Komorowski J; Jankiewicz-Wika J; Siejka A; Lawnicka H; Kłysik A; Goś R; Majos A; Stefańczyk L; Stepień H
    Klin Oczna; 2007; 109(10-12):457-60. PubMed ID: 18488396
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiation Therapy for Orbitopathy of Thyroid Eye Disease.
    Farach A; Carpenter LS
    Int Ophthalmol Clin; 2016; 56(1):81-93. PubMed ID: 26626934
    [No Abstract]   [Full Text] [Related]  

  • 55. [Thyroid orbitopathy and diabetes].
    Cáp J
    Vnitr Lek; 2007 May; 53(5):524-7. PubMed ID: 17642437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment of thyroid ophthalmopathy--a clinical case].
    Andrei S; Zemba M; Zugravu V; Enache V; Renetti A; Spiroiu C
    Oftalmologia; 2007; 51(1):49-55. PubMed ID: 17605272
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Role of Biological Agents and Immunomodulators in Treatment Strategies for Thyroid Eye Disease: An Evidence-based Review.
    Ginter A; Migliori ME
    R I Med J (2013); 2016 Jun; 99(6):26-9. PubMed ID: 27247969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of corticosteroids to treat ocular inflammation.
    Holmberg BJ; Maggs DJ
    Vet Clin North Am Small Anim Pract; 2004 May; 34(3):693-705. PubMed ID: 15110979
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcome of tocilizumab treatment in corticosteroid-resistant thyroid eye disease.
    Pampín-Sánchez R; Martínez-Mugica-Barbosa C; Fonseca-Aizpuru EM; Barbazán-Vázquez FJ; Fernández-González B; Buznego-Súárez L
    Med Clin (Barc); 2023 Feb; 160(3):113-117. PubMed ID: 36088128
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The cooperation between the ophthalmologist and the endocrinologist in the treatment of the endocrine orbitopathy].
    Ferková S; Chynoranský M; Podoba J; Cmelo J
    Cesk Slov Oftalmol; 2007 Apr; 63(2):108-16. PubMed ID: 17419323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.